Diabetes: upcoming dates

Recent

• Health09/23/2026@HealthDesk

  Lilly Presents eloraTZP Phase 2 Results at EASD 2026 in Milan

  Allianz MiCo, Via Demetrio Stratos, Bolla, Milan, Lombardy 20149, ItalyEli Lilly

  

  Starts 09/30/2026 2:30PM UTCSCHEDULEDDate confidence: SCHEDULEDGiven as scheduledHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all SCHEDULED pins86% CONFIDENCEOverall confidence: 86%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better6 days agoLilly's release lists "EloraTZP symposium | Wednesday, September 30, 2026 | 4:30 to 5:30 p.m. CEST", and the EASD^[2] 2026 Final Programme puts the session at 16:30 - 17:30 on Wednesday 30 September in Budapest Hall.

  First Phase 2 results for eloraTZP - Lilly's once-weekly amylin drug eloralintide combined with tirzepatide (Mounjaro, Zepbound) - in adults with obesity or overweight and type 2 diabetes, unveiled at an EASD symposium on amylin in Milan.

  10
• Health09/23/2026@HealthDesk

  FDA Authorizes Abbott's Libre Duo Glucose-Ketone Sensor

  1360 South Loop Road, Alameda, Alameda County, California, 94502, United StatesAbbott Laboratories

  

  Starts 08/25/2026CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins87% CONFIDENCEOverall confidence: 87%How well the pin's source and references back up its dates.Weighted average of how firmly 5 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better42 days agoThe release is datelined "ABBOTT PARK, Ill., Aug. 25, 2026" and says Abbott "today announced U.S. Food and Drug Administration (FDA^[2][3]) authorization of its Libre Duo 10 Day system"; the FDA's De Novo record gives the same decision date, 08/25/2026.

  The FDA authorized Abbott's Libre Duo 10 Day, the first wearable to continuously track both glucose and ketones, which alerts people with diabetes aged 2 and older to rising ketones before diabetic ketoacidosis.

  00
• Health09/23/2026@HealthDesk

  Abbott Corrects FreeStyle Libre 3 Sensors Over False Low Readings

  Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories

  

  Starts 11/24/2025CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins88% CONFIDENCEOverall confidence: 88%How well the pin's source and references back up its dates.Weighted average of how firmly 4 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better316 days agoAbbott's release is datelined "ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction", and the FDA^[4] recall page says "On November 24, 2025, Abbott Diabetes Care sent all affected customers a letter".

  Abbott began a medical device correction for about 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S. after internal testing found some give incorrect low glucose readings, an issue it linked to 736 severe adverse events and seven deaths worldwide. The FDA later made it a Class I recall.

  00
• Labour09/24/2026@EconDesk

  Dexcom Files Notice of 319 Layoffs at Its San Diego Headquarters

  Dexcom, Inc., 6290-6350 Sequence Drive, San Diego, California 92121Dexcom

  

  Starts 08/27/2025CONFIRMEDDate confidence: CONFIRMEDStated as firmHow firmly the source words the date: confirmed, scheduled, estimated, delayed or unverified.Show all CONFIRMED pins91% CONFIDENCEOverall confidence: 91%How well the pin's source and references back up its dates.Weighted average of how firmly 3 references, the source included, support the pin's start and end times; a reference counts half as much for every 180 days older than the newestShow all pins at 75% confidence or better1.1 years agoStated as firm, per SFGATE^[1]: "The company announced 319 layoffs in a WARN notice to California officials on August 27"; the Layoffs vertical pins the day staff were told. The separations took effect on 3 November 2025 ("They’ll officially lose their jobs on Nov. 3, the document said"; EDD WARN report effective date 11/03/2025).

  Glucose-monitor maker Dexcom told California it would lay off 319 workers at its Sequence Drive headquarters campus, effective 3 November 2025, as it keeps moving manufacturing from San Diego to Mesa, Arizona. The company said 196 of the jobs were in San Diego.

  00